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Regurgitant blood flow of mitral valves was studied by 
transesophageal Doppler color flow echocardiographic im- 
aging in I1 healthy volunteers (Group I), 25 cardiac 
patients with a native mitral valve (Group 2), 10 patients 
with a normally functioning BjGrk-Shiley mitral prosthesis 
without clinical evidence of mitral regurgitation (Group 3) 
and 10 patients with angiographic or surgical evidence of 
Bjiirk-Shiley mitral valve regurgitation (Group 4). Holosys- 
tolic regurgitant color jets were classified as type I or type 
II. The data were compared with results obtained with 
precordial techniques, i.e., continuous wave and Doppler 
color Row echocardiographic imaging (Groups 1 to 4) and 
left ventricular angiography or surgery (Groups 2 and 4). 
In Group I, transesophageal Doppler color flow imaging 
revealed no mitral regurgitant flow in 7 of the 11 patients 
and a type I jet in 4 patients that was detected in only 1 
patient by precordial techniques. In Group 2, angiography 
showed no mitral regurgitation in 20 patients and docu- 
mented mitral regurgitation in 5. Transesophageal Doppler 
color Row imaging detected in 4 of the 20 patients a type I 
Precordial Doppler color flow imaging provides vivid images 
of intracardiac blood flow and aids the rapid recognition of 
aberrant intracardiac flow patterns (I). This technique, how- 
ever, may not reveal mitral valve regurgitation because of 
attenuation of the ultrasound signal due to the distance 
involved, the interposition of calcified tissue or the presence 
of a valve prosthesis (?,3). Transesophageal Doppler color 
flow imaging theoretically facilitates detection of mitral 
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jet that was not visualized with precordial techniques in 2 
patients. Type II jets were detected by the transesophageal 
technique in all five patients with proven mitral regurgita- 
tion and were also visualized with precordial echocardiog 
raphy. All patients in Group 3 showed two identical type I 
jets that were not detected with precordial echocardiog- 
raphy. In Group 4, transesophageal Doppler color flow 
imaging revealed a type II jet in all 10 patients and, in 
addition, a type I jet in 7; the precordial continuous wave 
and Doppler color flow techniques detected mitral regurgi- 
tation in 6 and 3 patients, respectively. 
From this study it is concluded that transesophageal 
Doppler color flow imaging is an extremely sensitive 
method for the detection of mitral regurgitation. The 
unique position of the transesophageal transducer behind 
the BjGrk-Shiley mitral prosthesis makes it the technique of 
choice for the evaluation of prosthetic mitral valve regur- 
gitation. 
(J Am Co11 Cardiol 1989;13:95-9) 
valve regurgitation as the transducer is closer to the mitral 
valve and provides an unobstructed view. This study was 
designed to determine the systolic mitral valve flow charac- 
teristics imaged by transesophageal Doppler color flow echo- 
cardiography in healthy volunteers, patients with valvular or 
coronary artery disease, or both. and patients with a Bjiirk- 
Shiley mitral valve prosthesis. The results were compared 
with those obtained with precordial continuous wave and 
Doppler color flow echocardiography, and left ventricular 
angiography or surgery. when performed. 
Methods 
Study groups. Approval from our Committee on Human 
Research was granted and informed consent was obtained 
from each subject. 
Grorrp I comprised I I healthy volunteers (8 men and 3 
96 TAAMS ET AL. JACC Vol. 13, No. I 
TRANSESOPHAGEAL DOPPLER COLOR FLOW IMAGING January 1989:95-Y 
women aged 20 to 37 years [mean 311) with no history of 
cardiac disease or cardiac symptoms. One subject was 
studied three times. 
Group 2 included 25 patients (15 men and 10 women aged 
22 to 71 years [mean 551) with valvular or coronary artery 
disease, or both and a native mitral valve. All patients had 
undergone left ventricular angiography within 10 days to 4 
months of the transesophageal study. 
Group 3 comprised 10 patients with a Bjiirk-Shiley mitral 
valve prosthesis (7 men and 3 women aged 31 to 72 years 
[mean 591). These patients clinically had no signs of mitral 
regurgitation after implantation of the prosthesis, and pre- 
sented with an uneventful postoperative course. 
Group 4 included 10 patients with a Bjiirk-Shiley mitral 
valve prosthesis (6 men and 4 women aged 36 to 76 years 
[mean 631). Nine patients had signs and symptoms necessi- 
tating left ventricular angiography within 2 months of the 
transesophageal study. All of these nine patients had mitral 
valve regurgitation and seven had concomitant tricuspid 
regurgitation. Four patients required reoperation for para- 
valvular mitral regurgitation. One critically ill patient (Table 
1, Case 6) with three mechanical valves and suspected 
dehiscence of the mitral valve prosthesis underwent cardiac 
surgery for mitral valve regurgitation within 2 days after the 
transesophageal study. 
All patients (Groups 1 to 4) had a precordial continuous 
wave and Doppler color flow echocardiographic study in the 
week before the transesophageal study. 
Equipment and performance. Precordial studies were 
performed with use of a real-time two-dimensional Doppler 
flow imaging system and a 3.7 MHz transducer (Toshiba 
SSH-65A). For transesophageal studies a 3.7 MHz phased- 
array transducer mounted at the tip of a gastroscope tube 
was employed. The procedure of transesophageal echocar- 
diography in this study was performed as previously de- 
scribed (4). Blood flow toward the transducer was encoded 
in red and flow away from the transducer was encoded in 
blue. In proportion to the extent of turbulence the color hue 
varied from red to yellow and from blue to cyan. Images 
were stored on 0.75 in. (1.905 cm) videotape. 
Evaluation of regurgitant flow. Mitral valve flow charac- 
teristics were analyzed by an observer unaware of the 
subjects’ clinical history or results of other techniques. After 
frame by frame off-line analysis, mitral regurgitant flow was 
diagnosed if color flow imaging indicated blood flow into the 
left atrium through the mitral valve during systole. Onset of 
the regurgitant flow and duration, length, width and color 
characteristics of the flow were evaluated. The following 
types of color jets were observed: type l-a holosystolic, 
short (~30 mm), narrow (<IO mm) and predominantly red 
jet; type 11-a holosystolic, long (>30 mm) or broad (>lO 
mm), or both, and multicolored jet (Fig. 1). Type I jets were 
directed toward the center of the left atrium whereas type II 
jets were either directed toward the center of the left atrium 
or eccentrically directed. 
Results 
Transesophageal Doppler color flow echocardiography 
was completed without complication and within 15 min in all 
subjects. 
Group 1. Precordial continuous wave and Doppler color 
flow imaging revealed no mitral regurgitation in 10 of the 1 I 
volunteers and none of these participants showed signs of 
mitral valve prolapse. In one subject, precordial continuous 
wave and Doppler color flow studies revealed a small 
amount of mitral valve regurgitation (Table 1; Case II). The 
transesophageal Doppler color flow study revealed no mitral 
regurgitant flow in seven and a type I jet in four of the 
volunteers (Fig. 2). In one of these four subjects (Case 11) 
mitral regurgitation had also been noted with the precordial 
Doppler color flow study. 
In one volunteer with a type I jet, the transesophageal 
examination was repeated twice during an interval of 4 
months and the color jet was identical in all three studies. In 
this subject precordial Doppler color flow study revealed no 
mitral regurgitation, whereas the jet was clearly evident 
from the simultaneously conducted transesophageal exami- 
nation. 
Group 2. Left ventricular angiograms of 20 of the 25 
patients with a native mitral valve showed no mitral regur- 
gitation. In 4 of these 20 patients, a type I jet was noted on 
transesophageal Doppler color flow imaging, and its features 
were similar to those of the jet observed in the volunteers 
(Table 1). Results of precordial continuous wave and Dop- 
pler color flow imaging were positive for mitral regurgitation 
in two of these four patients. Reanalysis of the 20 angiograms 
confirmed the apparent competence of the mitral valve. 
Five of the 25 ungiogratns dernonstruted mitral regurgi- 
tution that was mild in one patient and severe in four 
patients. Transesophageal Doppler color flow imaging re- 
vealed a type II jet in all. Precordial continuous wave and 
Doppler color flow imaging detected holosystolic mitral 
valve regurgitation in all five patients. 
Group 3. Precordial continuous wave and Doppler color 
flow studies had not indicated mitral regurgitation in any of 
the 10 patients with a Bjiirk-Shiley mitral valve. Transesoph- 
ageal Doppler color flow study detected two identical type I 
jets in all 10 patients (Fig. 1 and 3, Table 1). 
Group 4. Transesophageal Doppler color flow imaging 
revealed a type II jet in all IO patients and an additional type 
I jet in 7 patients (Fig. 1 and 4). Precordial continuous wave 
Doppler and color flow imaging disclosed holosystolic mitral 
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Figure 1. Mitral valve regurgitation. Diagram showing features of 
holosystolic mitral valve regurgitant flow observed with transesoph- 
ageal color Doppler echocardiography in the native mitral valve and 
Bjiirk-Shiley prosthetic mitral valve. LA = left atrium; I = type I 
regurgitant jet; II = type II regurgitant jet. 
regurgitation in only six and three patients, respectively 
(Table 1). 
Figure 2. Transesophageal Doppler color flow images obtained in a 
healthy volunteer (Group I, Case 8). A, The two-dimensional image 
shows a type I jet in the left atrium (LA) predominantly encoded in 
red. B, M-mode recording through this jet displays holosystolic 
regurgitant flow (between arrows). LV = left ventricle. 
Figure 3. A systolic transesophageal Doppler color How still-frame 
showing 2 type 1 jets in a patient with a normal functioning 
BjOrk-Shiley mitral valve (Group 3). ,4bbrcviationj as in Figure 2. 
Discussion 
Transesophageal Doppler color flow imaging revealed a 
specific color pattern of holosystolic mitral regurgitation 
(type 1) to be designated as physiologic backflow that must 
be distinguished from pathologic mitral regurgitation (type 
II). 
Patients with a native mitral valve. A type 1 jet was 
observed in 36% of the healthy volunteers and in 20% of the 
cardiac patients with a native mitral valve who had shown no 
previous evidence of regurgitation. A simultaneous trans- 
esophageal M-mode and pulsed Doppler recording of this jet 
showed holosystolic mitral regurgitation (Fig. 21, further 
validating the suspicion that this type of jet represented 
regurgitant flow. A type II jet was dctectcd in all patients 
with a native mitral valve in whom a similar jet had been 
revealed with precordial continuous wave Doppler, and 
Figure 4. A systolic transesophageal Doppler color flow still-frame 
from a patient with a Bjiirk-Shiley mitral valve (Group IV, Case 7). 
Both a type I (arrow 1) and a type II (arrow 2) holosystolic 
regurgitant color jet are identified. In addition. tricuspid valve 
regurgitation is seen (arrow 3). Abbreviations as in Figure 1. 
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Table 1. Detection of Mitral Regurgitation in Healthy Volunteers 
(Group I), Cardiac Patients With a Native Mitral Valve (Group 2) 
and Patients With a Bjiirk-Shiley Mitral Valve Without (Group 3) 
and With (Group 4) Evidence of Mitral Valve Regurgitation 
Precordial 
Case No. 
Angio TEDC CW Doppler Doppler Color 
MR MR MR MR 
Group 1 (n = II) 
I to 7 
8 
9 
IO 
II 
Group 2 (n = 25) 
1 to 16 
17 
18 
19 
20 
21 
22* 
23* 
24* 
25” 
Group 3 (n = 10) 
1 to 10 
Group 4 (n = IO) 
1 
2 
3 
4 
5 
6* 
I* 
8* 
9* 
lo* 
NP 
NP 
NP 
NP 
NP 
_ 
_ 
_ 
It 
3t 
4+ 
4t 
4t 
NP 
1t 
It 
2t 
2t 
2t 
NP 
3t 
3t 
3t 
3t 
I 
I 
1 
I 
_ 
1 
1 
I 
I 
11 
II 
II 
II 
II 
I 
I,11 
I,11 
I. II 
I, II 
II 
II 
1, II 
I, II 
1. II 
II 
_ _ 
t t 
_ _ 
t t 
t t 
_ _ 
t t 
t t 
+ t 
t t 
t t 
t t 
_ 
t _ 
t t 
t t 
*Required surgery for mitral valve regurgitation. Angio = left ventricular 
angiography; CW = continuous wave; MR = mitral regurgitation; NP = not 
performed; TEDC = transesophageal Doppler color imaging; It, 4t = 
angiographic degree of mitral regurgitation; - = absent; t = present; I = 
type I jet; II = type II jet. 
color flow imaging and angiography. Thus, transesophageal 
Doppler color flow imaging offered no substantial advantage 
in the detection of pathologic mitral regurgitation of the 
native mitral valve. 
Regurgitant flow patterns have been documented with 
precordial Doppler flow imaging in healthy persons, but with 
a predominance of right-sided valve regurgitation (5-7). The 
incidence of this physiologic backflow in apparently normal 
mitral valves varies widely from 0 to 40% (5). In our study 
the results of precordial and transesophageal Doppler color 
flow imaging substantiate in Group 1 (normal volunteers) a 
fourfold and in Group 2 (coronary or valvular disease) a 
twofold higher sensitivity of the transesophageal technique 
in the detection of a regurgitant flow over the mitral valve. 
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On the other hand, false negative precordial Doppler flow 
studies have been reported, especially in the presence of 
angiographically documented mild mitral valve regurgita- 
tion, in patients with a native (2,7) or a mechanical mitral 
valve (8). 
This gives rise to the question as to why mitral regurgi- 
tation can be missed with conventional diagnostic tech- 
niques. With precordial echocardiographic methods the re- 
gurgitant jet is observed from a greater distance than with 
transesophageal methods and an interfering calcified or 
prosthetic valve may be interposed (3). Angiography could 
overcome these problems. However, there are fundamental 
differences between what is detected by these various meth- 
ods. Angiography maps the position of an indicator carried 
by blood flow, whereas Doppler color flow imaging maps 
velocity of blood flow. Therefore, a small volume of regur- 
gitant flow at high velocity may produce a vivid Doppler 
color flow signal but carry an insignificant amount of indica- 
tor for detection on the angiogram. 
Since the introduction of transesophageal two-dimen- 
sional echocardiography there has been concern about the 
possible dangers of this technique. More than 500 studies 
have been performed in our unit; all were well tolerated. 
Only two episodes of paroxysmal atria1 fibrillation occurred, 
and both were terminated by repositioning the scope. 
The possibility that the transesophageal examination it- 
self may induce mitral regurgitation has been excluded by a 
simultaneously conducted study. Although we could clearly 
localize the origin and extent of the regurgitant jet with the 
transesophageal approach, we were unable to find the jet 
from the precordium using the same ultrasonograph at the 
same time (Fig. 2). 
Patients with a Bjiirk-Shiley mitral valve. In the presence 
of a normally functioning Bjdrk-Shiley mitral valve prosthe- 
sis, transesophageal Doppler color flow imaging revealed 
two identical type I jets in all patients, but these jets were not 
detected with precordial Doppler studies. The type I regur- 
gitant color jets are inherent to the design of the prosthesis 
(9,lO); they represent I) dynamic regurgitation (i.e., blood 
volume necessary to close the disc), and 2) static regurgita- 
tion (i.e., blood volume passing the disc and housing during 
systole) (11). 
Among the patients with a Bjork-Shiley mitral prosthesis 
and angiographically or surgically documented mitral regur- 
gitation, a type II jet was always recorded. Thus it appears 
that the presence of a type II jet on transesophageal Doppler 
color flow studies is 100% sensitive and specific for detection 
of angiographically or surgically documentable pathologic 
prosthetic mitral valve regurgitation. This is not surprising 
because the regurgitant jet in the left atrium is unobstruc- 
tively observed, behind the prosthesis, by the esophageal 
transducer. Because of interposition of the mitral prosthesis, 
precordial continuous wave and Doppler color flow imaging 
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failed to identify pathologic prosthetic mitral regurgitation, 
respectively, in and 7 of the 10 patients in Group 4. 
Conclusions. This study describes the different systolic 
flow patterns observed with transesophageal Doppler color 
flow imaging in the native mitral valve and Bjork-Shiley 
mitral prosthesis. Whereas Miyatake et al. (2) documented 
four grades of mitral regurgitation using precordial Doppler 
color flow imaging, we were able with the transesophageal 
approach to distinguish two types of regurgitation. The 
distinction between type 1 and type II jets was clear. Type I 
jets were not pathologic, but type 11 jets were always 
associated with pathologic mitral regurgitation. Having de- 
tected the pathologic regurgitant jet with trdnsesophageal 
Doppler color flow imaging, it was, however. not possible to 
make further estimations concerning the significance of the 
regurgitation. Analysis of type II jets with respect to size and 
relative ratio of the jet to left atrial size allowed no subclas- 
sification in our study groups. In case of doubt about the 
type of jet, a close clinical follow-up is recommended. 
We thank Kee$ Ligtvoet for technical and editorial as\i\tance 
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